Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 1/2013

01.01.2013 | Cataract

Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens

verfasst von: Kazuki Matsuura, Chikako Suto, Junsuke Akura, Yoshitsugu Inoue

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Intracameral moxifloxacin is currently administered by injecting small doses (0.05–0.2 mL) of either undiluted or diluted solutions. It is difficult to ensure delivery of small amounts of antibiotic into the area behind the intraocular lens (IOL). Moreover, the anterior chamber pressure decreases as the tip of irrigation is removed, often leading to contaminated fluid flowing into the chamber. Conventional intracameral injection administers the diluted antibiotic without irrigating the recontaminated anterior chamber. Therefore, we developed a method of intracameral moxifloxacin delivery which flushes both the anterior chamber and the area behind the IOL immediately after surgery.

Methods

Surgical technique (bag and chamber flushing = BC flushing): After removing the viscosurgical device, 1.5–1.8 mL diluted moxifloxacin was injected. Both the anterior chamber and the area behind the IOL were irrigated by lifting the IOL edge so that a stream of solution could circulate behind the IOL. Experiment 1 (pig): The anterior chamber was filled with condensed milk, and irrigated with 150-fold diluted moxifloxacin (33.3 μg/mL) in six eyes (BC flushing) to observe the irrigating effect. The anterior aqueous humor was sampled. Experiment 2 (human): A conventional intracameral injection (500 μg/mL) or BC flushing (33.3 μg/mL) was followed by sampling 0.1 mL of the anterior aqueous humor in six eyes each. High-performance liquid chromatography was performed to determine antibiotic levels.

Results

Experiment 1: The antibiotic concentration in the anterior chamber was 33.0 μg/mL (99.0 % was displaced). The area behind the IOL was not effectively irrigated without inserting the cannula tip. Experiment 2: The final antibiotic concentration was 152.3 μg/mL using the conventional method and 29.4 μg/mL using the BC flushing (88.3 % was displaced).

Conclusion

BC flushing technique enables surgeons to completely displace the anterior chamber including the posterior IOL surface, resulting in effective irrigation and a stable antibiotic concentration in virtually all cases.
Literatur
1.
Zurück zum Zitat John T, Sims M, Hoffman C (2000) Intraocular bacterial contamination during sutureless, small incision, single-port phacoemulsification. J Cataract Surg 26:1786–1792CrossRef John T, Sims M, Hoffman C (2000) Intraocular bacterial contamination during sutureless, small incision, single-port phacoemulsification. J Cataract Surg 26:1786–1792CrossRef
2.
Zurück zum Zitat Tervo T, Ljungberg P, Kautiainen T, Pusk P, Leht I, Raivio I, Järvinen E, Kuusela P, Tarkkanen A (1999) Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg 25:65–71PubMedCrossRef Tervo T, Ljungberg P, Kautiainen T, Pusk P, Leht I, Raivio I, Järvinen E, Kuusela P, Tarkkanen A (1999) Prospective evaluation of external ocular microbial growth and aqueous humor contamination during cataract surgery. J Cataract Refract Surg 25:65–71PubMedCrossRef
3.
Zurück zum Zitat Wada T, Kozai S, Tajika T, Sakai H, Suzuki T, Ohashi Y (2008) Prophylatic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits. J Ocul Pharmacol Ther 24:278–289PubMedCrossRef Wada T, Kozai S, Tajika T, Sakai H, Suzuki T, Ohashi Y (2008) Prophylatic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits. J Ocul Pharmacol Ther 24:278–289PubMedCrossRef
4.
Zurück zum Zitat Wallin T, Parker J, Jin Y, Kefalopoulos G, Olson R (2005) Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg 31:735–741PubMedCrossRef Wallin T, Parker J, Jin Y, Kefalopoulos G, Olson R (2005) Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg 31:735–741PubMedCrossRef
5.
Zurück zum Zitat Endophthalmitis Surgery Group, European Society of Cataract & Refractive Surgeons (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: result of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988CrossRef Endophthalmitis Surgery Group, European Society of Cataract & Refractive Surgeons (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: result of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988CrossRef
6.
Zurück zum Zitat Espiritu CR, Ramon CG, Caparas VL, Bolinao JG (2007) Safety of prophylactic intracameral moxifloxacin 0.5 % ophthalmic solution in cataract patients. J Cataract Refract Surg 33:63–68PubMedCrossRef Espiritu CR, Ramon CG, Caparas VL, Bolinao JG (2007) Safety of prophylactic intracameral moxifloxacin 0.5 % ophthalmic solution in cataract patients. J Cataract Refract Surg 33:63–68PubMedCrossRef
7.
Zurück zum Zitat Kim SY, Park YH, Lee YC (2008) Comparison of the effect of intracameral moxifloxacin and cefazolin on rabbit corneal endothelial cells. Clin Experiment Ophthalmol 36:367–370PubMedCrossRef Kim SY, Park YH, Lee YC (2008) Comparison of the effect of intracameral moxifloxacin and cefazolin on rabbit corneal endothelial cells. Clin Experiment Ophthalmol 36:367–370PubMedCrossRef
8.
Zurück zum Zitat Lane SS, Osher RH, Masket S, Belani S (2008) Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg 34:1451–1459PubMedCrossRef Lane SS, Osher RH, Masket S, Belani S (2008) Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg 34:1451–1459PubMedCrossRef
9.
Zurück zum Zitat O’Brien TP, Arshinoff SA, Mah FS (2007) Perspectives on antibiotics for postoperative endopthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg 33:1790–1800PubMedCrossRef O’Brien TP, Arshinoff SA, Mah FS (2007) Perspectives on antibiotics for postoperative endopthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg 33:1790–1800PubMedCrossRef
10.
Zurück zum Zitat Suzuki T, Wada T, Kozai S, Ike Y, Gilmore MS, Ohashi Y (2008) Contribution of secreted proteases to the pathogenesis of postoperative Enterococcus faecalis endophthalmitis. J Cataract Refract Surg 34:1776–1784PubMedCrossRef Suzuki T, Wada T, Kozai S, Ike Y, Gilmore MS, Ohashi Y (2008) Contribution of secreted proteases to the pathogenesis of postoperative Enterococcus faecalis endophthalmitis. J Cataract Refract Surg 34:1776–1784PubMedCrossRef
11.
Zurück zum Zitat Kernt M, Neubauer AS, Liegl RG, Lackerbauer CA, Eibl KH, Alge CS, Ulbig MW, Kampik A (2009) Intracameral moxifloxacin: In vitro safety on human ocular cells. Cornea 28:553–561PubMedCrossRef Kernt M, Neubauer AS, Liegl RG, Lackerbauer CA, Eibl KH, Alge CS, Ulbig MW, Kampik A (2009) Intracameral moxifloxacin: In vitro safety on human ocular cells. Cornea 28:553–561PubMedCrossRef
12.
Zurück zum Zitat Mather R, Karenchak LM, Romanowski EG, Kowalski EG (2002) Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133:463–466PubMedCrossRef Mather R, Karenchak LM, Romanowski EG, Kowalski EG (2002) Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133:463–466PubMedCrossRef
13.
Zurück zum Zitat Blondeau JM (1999) A review of comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones. J Antimicrob Chemother 43(suppl B):1–11PubMedCrossRef Blondeau JM (1999) A review of comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones. J Antimicrob Chemother 43(suppl B):1–11PubMedCrossRef
14.
Zurück zum Zitat Kowalski RP, Dhaliwal DK, Karenchak LM, Romanpwski EG, Mah FS, Ritterband DC, Gordon YJ (2003) Gatifloxacin and moxifloxacin; an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136:500–505PubMedCrossRef Kowalski RP, Dhaliwal DK, Karenchak LM, Romanpwski EG, Mah FS, Ritterband DC, Gordon YJ (2003) Gatifloxacin and moxifloxacin; an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 136:500–505PubMedCrossRef
15.
Zurück zum Zitat Kodjikian L, Renaud FN, Roques C, Garweg JG, Pellon G, Freney J, Burillon C (2005) In vitro influence of vancomycin on adhesion of a Staphylococcus epidermidis strain encoding intracellular adhesion locus ica to intraocular lenses. J Cataract Refract Surg 31:1050–1058PubMedCrossRef Kodjikian L, Renaud FN, Roques C, Garweg JG, Pellon G, Freney J, Burillon C (2005) In vitro influence of vancomycin on adhesion of a Staphylococcus epidermidis strain encoding intracellular adhesion locus ica to intraocular lenses. J Cataract Refract Surg 31:1050–1058PubMedCrossRef
Metadaten
Titel
Bag and chamber flushing: a new method of using intracameral moxifloxacin to irrigate the anterior chamber and the area behind the intraocular lens
verfasst von
Kazuki Matsuura
Chikako Suto
Junsuke Akura
Yoshitsugu Inoue
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 1/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-012-2098-1

Weitere Artikel der Ausgabe 1/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 1/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.